Cyclooxygenase-2 in the hippocampus is up-regulated in Alzheimer's disease but not in variant Alzheimer's disease with cotton wool plaques in humans

Neuroscience Letters

Volumn 343, Issue 3, 2003, Pages 175-179

  Yokota, Osamu ^a   Terada, Seishi ^a   Ishizu, Hideki ^a,b   Ishihara, Takeshi ^a   Ujike, Hiroshi ^a   Nakashima, Hanae ^a   Nakashima, Yoshihiko ^c   Kugo, Aki ^a   Checler, Frédéric ^d   Kuroda, Shigetoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Zikei Institute of Psychiatry   (Japan)

^c Sanyo Hospital   (Japan)

^d CNRS   (France)

Author keywords

Alzheimer's disease; Cotton wool plaque; Cyclooxygenase 2; Hippocampus; Inflammation; Non steroidal anti inflammatory drugs

Indexed keywords

AMYLOID BETA PROTEIN; CYCLOOXYGENASE 2; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME REGULATION; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; BIOSYNTHESIS; BRAIN; CELL COUNT; ENZYMOLOGY; GENETICS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PATHOLOGY; PYRAMIDAL NERVE CELL; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CELL COUNT; CYCLOOXYGENASE 2; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAMIDAL CELLS; TEMPORAL LOBE; UP-REGULATION;

EID: 0037872107     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00339-2     Document Type: Article

References (16)

1. Andreasson K.I., Savonenko A., Vidensky S., Goellner J.J., Zhang Y., Shaffer A., Kaufmann W.E., Worley P.F., Isakson P., Markowska A.L. Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J. Neurosci. 21:2001;8198-8209.
2. Barelli H., Lebeau A., Vizzavona J., Delaere P., Chevallier N., Drouot C., Marambaud P., Ancolio K., Buxbaum J.D., Khorkova O., Heroux J., Sahasrabudhe S., Martinez J., Warter J.M., Mohr M., Checler F. Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Mol. Med. 3:1997;695-707.
3. Chui D.H., Dobo E., Makifuchi T., Akiyama H., Kawakatsu S., Petit A., Checler F., Araki W., Takahashi K., Tabira T. Apoptotic neurons in Alzheimer's disease frequently show intracellular Abeta42 labeling. J. Alzheimer's Dis. 3:2001;231-239.
4. Crook R., Verkkoniemi A., Perez-Tur J., Mehta N., Baker M., Houlden H., Farrer M., Hutton M., Lincoln S., Hardy J., Gwinn K., Somer M., Paetau A., Kalimo H., Ylikoski R., Poyhonen M., Kucera S., Haltia M. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat. Med. 4:1998;452-455.
5. Ho L., Osaka H., Aisen P.S., Pasinetti G.M. Induction of cyclooxygenase (COX)-2 but not COX-1 gene expression in apoptotic cell death. J. Neuroimmunol. 89:1998;142-149.
6. Ho L., Pieroni C., Winger D., Purohit D.P., Aisen P.S., Pasinetti G.M. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. J. Neurosci. Res. 57:1999;295-303.
7. Ho L., Purohit D., Haroutunian V., Luterman J.D., Willis F., Naslund J., Buxbaum J.D., Mohs R.C., Aisen P.S., Pasinetti G.M. Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease. Arch. Neurol. 58:2001;487-492.
8. Hoozemanz J.J., Bruckner M.K., Rozemuller A.J., Veerhuis R., Eikelenboom P., Arendt T. Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer's disease temporal cortex. J. Neuropathol. Exp. Neurol. 61:2002;678-688.
9. Le T.V., Crook R., Hardy J., Dickson D.W. Cotton wool plaques in non-familial late-onset Alzheimer disease. J. Neuropathol. Exp. Neurol. 60:2001;1051-1061.
10. Luterman J.D., Haroutunian V., Yemul S., Ho L., Purohit D., Aisen P.S., Mohs R., Pasinetti G.M. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch. Neurol. 57:2000;1153-1160.
11. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:1995;195-218.
12. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
13. Pasinetti G.M., Aisen P.S. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience. 87:1998;319-324.
14. Rogers J., Kirby L.C., Hempelman S.R., Berry D.L., McGeer P.L., Kaszniak A.W., Zalinski J., Cofield M., Mansukhani L., Willson P. Clinical trial of indomethacin in Alzheimer's disease. Neurology. 43:1993;1609-1611.
15. Tabira T., Chui D.H., Kuroda S. Significance of intracellular Abeta42 accumulation in Alzheimer's disease. Front. Biosci. 7:2002;a44-a49.
16. Tabira T., Chui D.H., Nakayama H., Kuroda S., Shibuya M. Alzheimer's disease with spastic paraparesis and cotton wool plaques. J. Neurosci. Res. 70:2002;367-372.